Celanese Corp·4

Mar 11, 4:41 PM ET

GALANTE EDWARD G 4

4 · Celanese Corp · Filed Mar 11, 2026

Research Summary

AI-generated summary of this filing

Updated

Celanese (CE) Director Edward Galante Receives Phantom Stock Award

What Happened

  • Edward G. Galante, a director of Celanese Corporation (CE), was granted/received 4.028 phantom shares on 2026-03-10 at a reported per-share value of $50.67, a total reported value of about $204. This transaction is an award/acquisition of derivative phantom stock (transaction code A), not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-03-10; filing date: 2026-03-11 (timely).
  • Reported amount: 4.028 phantom shares at $50.67 each; total reported value ≈ $204.
  • Shares owned after transaction: Not specified in the filing.
  • Footnotes: F1 — each phantom share represents the right to receive one share of Common Stock. F2 — these phantom shares are dividend equivalents under the 2008 Deferred Compensation Plan and will be payable in shares of Common Stock per the Plan.
  • Transaction type: Derivative award (phantom stock), code A.

Context

  • Phantom stock awards are bookkeeping rights that convert to actual shares (or their cash/share equivalent) under plan rules; they are common as deferred, tax-advantaged compensation and do not reflect an open-market buy or sale. This small-value dividend-equivalent award is routine compensation activity and should not be read alone as a buy/sell signal.

Insider Transaction Report

Form 4
Period: 2026-03-10
Transactions
  • Award

    Phantom Stock

    [F1][F2]
    2026-03-10$50.67/sh+4.028$2046,806.793 total
    Common Stock (4.028 underlying)
Footnotes (2)
  • [F1]Each share of phantom stock represents the right to receive one share of Common Stock.
  • [F2]The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan.
Signature
/s/ Christine Dryden, Attorney-in-Fact for Edward G. Galante|2026-03-11

Documents

1 file
  • 4
    wk-form4_1773261712.xmlPrimary

    FORM 4